Archive for June, 2010

Massachusetts class-action bonanza

The Boston Globe reports that plaintiff’s securities law firms have become cash cows for Massachusetts Attorney General Martha Coakley and Treasurer Timothy Cahill, who oversee the pension funds that strike representation deals with the lawyers. “Spokeswomen for Cahill and Coakley said the contributions played no part in the selection of the law firms, which were chosen in a competitive process five years ago.”

June 18 roundup

  • “When the country went cold turkey”: Tyler Cowen reviews Last Call, Daniel Okrent’s history of Prohibition [Business Week]
  • Phrases never to put in email, e.g., “We Probably Shouldn’t Put This in Email” [Balasubramani, SpamNotes]
  • “My biggest wish was that I would get a cease and desist from the company that publishes Marmaduke” [Walker, Reason “Hit and Run”]
  • California proposal to jail parents for kids’ truancy [Valerie Strauss/WaPo via Alkon] Parents arrested on charges of forging doctor sick note to excuse third grader [Glenn Reynolds, Dan Riehl]
  • UK judge: NHS need not fund transsexual’s breast enlargement [Mail]
  • “Charitable Foundation Leader Alarmed by Government Intrusions into Philanthropy” [WLF Legal Pulse]
  • Missed earlier: “Stalking Victims’ Duty to Warn Employees, Lovers, Visitors, and Others?” [Volokh]
  • “Overturning Iqbal and Twombly Would Encourage Frivolous Litigation” [Darpana Sheth, Insider Online]

Malpractice systems in other countries

They do things very differently elsewhere, reports the AMA’s American Medical News (via White Coat):

“Nobody is as hospitable to potential liability as we are in this country,” said Richard A. Epstein, director of the law and economics program at the University of Chicago Law School. “The unmistakable drift is we do much more liability than anybody else, and the evidence on improved care is vanishingly thin.”

In other news, the Obama administration is now rolling out its test project grants on med-mal; for reasons already aired in this space, Carter Wood isn’t expecting much.

Drugmaker to halt production of sedative

Following a Nevada jury’s highly controversial $500 million verdict over allegedly inadequate warnings against multiple patient use, as well as bad publicity over possible abuse by music legend Michael Jackson, “Israel-based Teva Pharmaceutical Industries recently announced it will stop production of its sedative propofol, which many worry will intensify an already existing shortage of one of the most widely used anesthetics in the United States.” [Abnormal Use, earlier]